Table 4.
Triglyceride categories and risk for CVD mortality among 26 570 adults
| Triglyceride (mg/dL) | n | HRa | 95% CI | P-valueb | P for trend |
|---|---|---|---|---|---|
| All participants (n = 26 570) | |||||
| ȃ<150 (normal) | 18 802 | 1 | Reference | NA | 0.668 |
| ȃ150–199 (borderline high) | 3714 | 1.02 | 0.88–1.17 | 0.830 | |
| ȃ200–499 (high) | 3726 | 1.04 | 0.91–1.20 | 0.557 | |
| ȃ≥500 (very high) | 328 | 1.25 | 0.86–1.83 | 0.243 | |
| Participants without diabetes (n = 22 592) | |||||
| ȃ<150 (normal) | 16 656 | 1 | Reference | NA | 0.575 |
| ȃ150–199 (borderline high) | 2978 | 0.97 | 0.83–1.14 | 0.718 | |
| ȃ200–499 (high) | 2764 | 0.88 | 0.74–1.05 | 0.160 | |
| ȃ≥500 (very high) | 194 | 0.93 | 0.48–1.81 | 0.840 | |
| Participants with diabetes (n = 3978) | |||||
| ȃ<150 (normal) | 2146 | 1 | Reference | NA | 0.015 |
| ȃ150–199 (borderline high) | 736 | 1.10 | 0.83–1.46 | 0.496 | |
| ȃ200–499 (high) | 962 | 1.44 | 1.12–1.85 | 0.004 | |
| ȃ≥500 (very high) | 134 | 1.66 | 1.01–2.70 | 0.044 | |
CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio.
Adjusted for age, sex, ethnicity, obesity, poverty–income ratio, education, physical activity, alcohol consumption, smoking status, survey period, hypercholesterolaemia, hypertension, diabetes, family history of diabetes, duration of diabetes, and diabetes medications.
Compared with those with normal triglycerides.